/People

Kristina Burow

Investor

Founder and Managing Partner at Pachamama Ventures · Managing Director at ARCH Venture Partners

United States

Writes $50K – $150M checks · typically $50K

Find your path to Kristina

Sign up to see every warm intro you have to Kristina

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Kristina. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

Kristina Burow, a biotech VC leader building companies in emerging biology, focuses on transformative neuropsychiatry and schizophrenia drugs for biologically defined subgroups, helping create Neumora, Orbital Therapeutics and Boundless Bio.

Contact· self-published, not guessed

Invests in

AI & Machine LearningBiotechDeep TechHardwareHealthtechMedical Devices

Deals · 13

Autobahn Therapeutics, Inc.Board seat

via ARCH Venture Partners · filed Aug 2024 · $120M raise

Boundless BioBoard seat

via ARCH Venture Partners · filed May 2021 · $105.6M raise

Vividion TherapeuticsBoard seat

via ARCH Venture Partners · filed May 2019 · $82M raise

Beam TherapeuticsBoard seat

via ARCH Venture Partners · filed Mar 2019 · $83.6M raise

Scholar Rock Holding Corp, Inc.Board seat

via ARCH Venture Partners · filed Jan 2018 · $47M raise

Sienna BiopharmaceuticalsBoard seat

via ARCH Venture Partners · filed May 2017 · $40.5M raise

TrelysBoard seat

via ARCH Venture Partners · filed Apr 2017 · $80K raise

BoragenBoard seat

via ARCH Venture Partners · filed Mar 2017 · $10.5M raise

MetacrineBoard seat

via ARCH Venture Partners · filed Nov 2016 · $37.8M raise

Scholar RockBoard seat

via ARCH Venture Partners · filed Jan 2016 · $40M raise

AgbiomeBoard seat

via ARCH Venture Partners · filed Aug 2015 · $34.5M raise

LyceraBoard seat

via ARCH Venture Partners · filed Jun 2015

ErascaQuoted

via ARCH Venture Partners · filed Apr 2020

press ↗

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Sources: SEC Form D filings · curated public sources.

Colleagues at Pachamama Ventures

Frequently asked questions

Who is Kristina Burow?
Kristina Burow, a biotech VC leader building companies in emerging biology, focuses on transformative neuropsychiatry and schizophrenia drugs for biologically defined subgroups, helping create Neumora, Orbital Therapeutics and Boundless Bio.
Where does Kristina Burow work?
Kristina Burow is Founder and Managing Partner at Pachamama Ventures and Managing Director at ARCH Venture Partners.
What does Kristina Burow invest in?
Kristina Burow invests in AI & Machine Learning, Biotech, Deep Tech, Hardware, Healthtech, Medical Devices.
What check size does Kristina Burow write?
Kristina Burow typically writes checks of $50K – $150M.
What boards does Kristina Burow sit on?
Kristina Burow holds tracked board seats at Agbiome, Autobahn Therapeutics, Inc., Beam Therapeutics, Boragen, Boundless Bio, Gossamer Bio, Lycera, Metacrine, Metsera, Mirador Therapeutics.
What companies has Kristina Burow invested in?
Investments tracked here include Autobahn Therapeutics, Inc., Dewpoint Therapeutics, Erasca, Gossamer Bio, Kilimanjaro Energy, Lycera, Magnet Biomedicine, Metsera, Mirador Therapeutics, Neumora Therapeutics, Orbital Therapeutics, Pretzel Therapeutics, and 6 more.

Founder mafias

About this profile. Compiled from public sources — Pachamama Ventures's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights